Log Out

Financial Comparison: Affinity Energy and Health (OTCMKTS:ALGXY) Vs. Absci (NASDAQ:ABSI)

Affinity Energy and Health (OTCMKTS:ALGXY – Get Rating) and Absci (NASDAQ:ABSI – Get Rating) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk.

Volatility and Risk

Affinity Energy and Health has a beta of 135.11, meaning that its stock price is 13,411% more volatile than the S&P 500. Comparatively, Absci has a beta of 1.18, meaning that its stock price is 18% more volatile than the S&P 500.

Get Affinity Energy and Health alerts:

Valuation and Earnings

This table compares Affinity Energy and Health and Absci's top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Affinity Energy and Health	$2.05 million	N/A	-$6.08 million	N/A	N/A
Absci	$4.78 million	64.75	-$100.96 million	($1.23)	-2.72

Affinity Energy and Health has higher earnings, but lower revenue than Absci.

Profitability

This table compares Affinity Energy and Health and Absci's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Affinity Energy and Health	N/A	N/A	N/A
Absci	-1,960.28%	-33.62%	-28.97%

Institutional and Insider Ownership

47.6% of Absci shares are held by institutional investors. 19.4% of Absci shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Analyst Ratings

This is a summary of recent ratings for Affinity Energy and Health and Absci, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Affinity Energy and Health	0	0	0	0	N/A
Absci	1	0	4	0	2.60

Absci has a consensus target price of $10.67, suggesting a potential upside of 218.41%. Given Absci's higher possible upside, analysts clearly believe Absci is more favorable than Affinity Energy and Health.

About Affinity Energy and Health

(Get Rating)

Affinity Energy and Health Limited operates as a plant-based health and wellbeing company in Australia, India, and the United States. It engages in developing technology to produce commercial quantities of algae and medicinal cannabis for supply to algae-based nutraceuticals, animal feed and aquaculture, medicinal cannabis, and biofuels markets. The company offers FeedMe Algae, an algae-based aqua feed; and algae-based biofuels. Affinity Energy and Health Limited was founded in 2007 and is based in Subiaco, Australia.

About Absci

(Get Rating)

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.

Receive News & Ratings for Affinity Energy and Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Affinity Energy and Health and related companies with MarketBeat.com's FREE daily email newsletter.

This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors’ financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. Moomoo makes no representation or warranty as to its adequacy, completeness, accuracy or timeliness for any particular purpose of the above content.

Moomoo is a financial information and trading app offered by Moomoo Technologies Inc.
In the U.S., investment products and services available through the moomoo app are offered by Moomoo Financial Inc., a broker-dealer registered with the U.S. Securities and Exchange Commission (SEC) and a member of Financial Industry Regulatory Authority (FINRA)/Securities Investor Protection Corporation (SIPC).
In Singapore, investment products and services available through the moomoo app are offered through Moomoo Financial Singapore Pte. Ltd. regulated by the Monetary Authority of Singapore (MAS). Moomoo Financial Singapore Pte. Ltd. is a Capital Markets Services Licence (License No. CMS101000) holder with the Exempt Financial Adviser Status. This advertisement has not been reviewed by the Monetary Authority of Singapore.
In Australia, financial products and services available through the moomoo app are provided by Futu Securities (Australia) Ltd, an Australian Financial Services Licensee (AFSL No. 224663) regulated by the Australian Securities and Investment Commission (ASIC). Please read and understand our Financial Services Guide, Terms and Conditions, Privacy Policy and other disclosure documents which are available on our websites https://www.futuau.com and https://www.moomoo.com/au. Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd. and Futu Securities (Australia) Ltd are affiliated companies.